| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin | 186 | 2013 | 1227 | 7.940 |
Why?
|
| Islets of Langerhans | 73 | 2014 | 568 | 4.790 |
Why?
|
| Diabetes Mellitus, Type 2 | 72 | 2014 | 1286 | 3.100 |
Why?
|
| Blood Glucose | 129 | 2013 | 913 | 2.720 |
Why?
|
| Glucose | 73 | 2013 | 704 | 2.670 |
Why?
|
| Insulin-Secreting Cells | 21 | 2016 | 453 | 2.510 |
Why?
|
| C-Peptide | 81 | 2013 | 191 | 2.300 |
Why?
|
| Diabetes Mellitus | 28 | 2015 | 811 | 1.880 |
Why?
|
| Trans-Activators | 9 | 2016 | 447 | 1.790 |
Why?
|
| Insulin Resistance | 33 | 2014 | 391 | 1.690 |
Why?
|
| Apoptosis | 17 | 2016 | 1752 | 1.580 |
Why?
|
| Homeodomain Proteins | 8 | 2016 | 566 | 1.460 |
Why?
|
| Obesity | 38 | 2011 | 1061 | 1.460 |
Why?
|
| Glucose Intolerance | 15 | 2012 | 101 | 1.390 |
Why?
|
| Glucose Tolerance Test | 42 | 2012 | 239 | 1.150 |
Why?
|
| Apoptosis Regulatory Proteins | 4 | 2014 | 201 | 1.120 |
Why?
|
| Calpain | 8 | 2010 | 113 | 0.990 |
Why?
|
| Glucagon | 37 | 2013 | 115 | 0.860 |
Why?
|
| Diabetes Mellitus, Type 1 | 22 | 2010 | 687 | 0.810 |
Why?
|
| Neurotensin | 3 | 2013 | 10 | 0.790 |
Why?
|
| Biomedical Research | 4 | 2015 | 471 | 0.750 |
Why?
|
| Membrane Proteins | 3 | 2014 | 1285 | 0.710 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2014 | 682 | 0.710 |
Why?
|
| Gastric Inhibitory Polypeptide | 3 | 2012 | 12 | 0.700 |
Why?
|
| Calcium | 20 | 2013 | 1196 | 0.690 |
Why?
|
| Animals | 108 | 2016 | 28902 | 0.680 |
Why?
|
| Eating | 15 | 2002 | 164 | 0.660 |
Why?
|
| Mice | 48 | 2016 | 12697 | 0.660 |
Why?
|
| Hyperglycemia | 11 | 2008 | 186 | 0.650 |
Why?
|
| Proinsulin | 16 | 2012 | 123 | 0.620 |
Why?
|
| Reference Values | 31 | 2009 | 612 | 0.600 |
Why?
|
| Hypoglycemic Agents | 12 | 2013 | 412 | 0.580 |
Why?
|
| Thiazolidinediones | 6 | 2005 | 76 | 0.570 |
Why?
|
| Diabetes Mellitus, Experimental | 10 | 2016 | 207 | 0.560 |
Why?
|
| Liver | 29 | 2007 | 1231 | 0.560 |
Why?
|
| Polycystic Ovary Syndrome | 5 | 2009 | 196 | 0.550 |
Why?
|
| Humans | 183 | 2015 | 98135 | 0.520 |
Why?
|
| Glucokinase | 8 | 2001 | 61 | 0.520 |
Why?
|
| Hypoglycemia | 14 | 2009 | 116 | 0.510 |
Why?
|
| Rats, Zucker | 15 | 2003 | 38 | 0.510 |
Why?
|
| Calcium-Binding Proteins | 3 | 2009 | 122 | 0.500 |
Why?
|
| Male | 139 | 2013 | 47109 | 0.470 |
Why?
|
| Circadian Rhythm | 15 | 2000 | 295 | 0.460 |
Why?
|
| Mitochondrial Proteins | 2 | 2010 | 131 | 0.460 |
Why?
|
| Fasting | 17 | 2010 | 166 | 0.430 |
Why?
|
| Thiazoles | 5 | 1998 | 126 | 0.430 |
Why?
|
| Chromans | 4 | 1998 | 28 | 0.420 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 2 | 2004 | 24 | 0.410 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2014 | 56 | 0.410 |
Why?
|
| Cell Death | 2 | 2014 | 257 | 0.410 |
Why?
|
| Mitochondria | 5 | 2006 | 650 | 0.400 |
Why?
|
| Adult | 100 | 2013 | 29564 | 0.400 |
Why?
|
| DNA-Binding Proteins | 7 | 2005 | 1255 | 0.380 |
Why?
|
| Leucine | 2 | 2003 | 57 | 0.370 |
Why?
|
| Glucose Clamp Technique | 15 | 2011 | 42 | 0.360 |
Why?
|
| Glucagon-Like Peptide 1 | 5 | 2013 | 65 | 0.360 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 312 | 0.350 |
Why?
|
| Exocytosis | 4 | 2009 | 109 | 0.350 |
Why?
|
| Mice, Knockout | 12 | 2014 | 2207 | 0.350 |
Why?
|
| Female | 115 | 2013 | 51570 | 0.350 |
Why?
|
| Rats | 28 | 2012 | 4072 | 0.350 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 3 | 2009 | 123 | 0.340 |
Why?
|
| Islets of Langerhans Transplantation | 6 | 2006 | 286 | 0.340 |
Why?
|
| Calcium Signaling | 4 | 2006 | 142 | 0.340 |
Why?
|
| NADP | 4 | 2006 | 48 | 0.340 |
Why?
|
| Necrosis | 2 | 2010 | 212 | 0.330 |
Why?
|
| Autophagy | 2 | 2009 | 177 | 0.330 |
Why?
|
| Incretins | 2 | 2009 | 15 | 0.320 |
Why?
|
| Somatostatin | 15 | 1998 | 61 | 0.320 |
Why?
|
| Genetic Variation | 5 | 2010 | 1445 | 0.320 |
Why?
|
| Mice, Transgenic | 12 | 2010 | 1604 | 0.320 |
Why?
|
| Receptor, Insulin | 7 | 2009 | 60 | 0.320 |
Why?
|
| Transcription Factors | 7 | 2005 | 1717 | 0.310 |
Why?
|
| TCF Transcription Factors | 1 | 2009 | 24 | 0.310 |
Why?
|
| Muscle, Skeletal | 4 | 2012 | 522 | 0.300 |
Why?
|
| ADP-ribosyl Cyclase 1 | 2 | 2006 | 19 | 0.300 |
Why?
|
| KATP Channels | 1 | 2009 | 18 | 0.300 |
Why?
|
| Metabolic Clearance Rate | 26 | 2005 | 118 | 0.300 |
Why?
|
| Dose-Response Relationship, Drug | 13 | 2006 | 1950 | 0.290 |
Why?
|
| Education, Graduate | 1 | 2009 | 10 | 0.290 |
Why?
|
| RNA, Messenger | 15 | 2014 | 2063 | 0.290 |
Why?
|
| Hyperinsulinism | 8 | 2009 | 44 | 0.290 |
Why?
|
| Models, Biological | 14 | 2008 | 1809 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 20 | 4 | 1996 | 32 | 0.290 |
Why?
|
| Pancreas | 8 | 2012 | 269 | 0.290 |
Why?
|
| Kinetics | 28 | 2002 | 1476 | 0.280 |
Why?
|
| Gene Expression | 10 | 2006 | 1320 | 0.280 |
Why?
|
| Signal Transduction | 10 | 2014 | 3621 | 0.280 |
Why?
|
| Mentors | 1 | 2009 | 103 | 0.280 |
Why?
|
| In Vitro Techniques | 13 | 2012 | 945 | 0.280 |
Why?
|
| History, 21st Century | 3 | 2015 | 196 | 0.280 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2009 | 103 | 0.270 |
Why?
|
| History, 20th Century | 3 | 2015 | 323 | 0.270 |
Why?
|
| Membrane Glycoproteins | 2 | 2006 | 446 | 0.250 |
Why?
|
| Dogs | 32 | 2004 | 639 | 0.250 |
Why?
|
| Diet, Reducing | 3 | 2009 | 28 | 0.250 |
Why?
|
| Lipoproteins | 3 | 1992 | 136 | 0.250 |
Why?
|
| Hydrocortisone | 12 | 1999 | 306 | 0.250 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2006 | 4 | 0.240 |
Why?
|
| Retinol-Binding Proteins | 1 | 2006 | 8 | 0.240 |
Why?
|
| Histocompatibility | 1 | 2006 | 71 | 0.240 |
Why?
|
| Cysteine Proteinase Inhibitors | 2 | 2003 | 52 | 0.240 |
Why?
|
| Up-Regulation | 3 | 2014 | 743 | 0.230 |
Why?
|
| Cells, Cultured | 7 | 2009 | 2855 | 0.230 |
Why?
|
| Monosaccharide Transport Proteins | 2 | 2004 | 76 | 0.230 |
Why?
|
| Triglycerides | 6 | 1996 | 233 | 0.230 |
Why?
|
| Gene Expression Regulation | 9 | 2009 | 2023 | 0.230 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2005 | 26 | 0.230 |
Why?
|
| Internal Medicine | 1 | 2009 | 338 | 0.230 |
Why?
|
| Bariatric Surgery | 1 | 2008 | 216 | 0.230 |
Why?
|
| Weight Loss | 7 | 2012 | 245 | 0.230 |
Why?
|
| Metformin | 2 | 1997 | 132 | 0.220 |
Why?
|
| Calcium Channels | 3 | 1996 | 180 | 0.220 |
Why?
|
| Lipids | 3 | 2009 | 293 | 0.220 |
Why?
|
| Aging | 7 | 2008 | 771 | 0.220 |
Why?
|
| Cell Survival | 6 | 2010 | 1014 | 0.210 |
Why?
|
| Infusions, Intravenous | 15 | 2013 | 412 | 0.210 |
Why?
|
| Egtazic Acid | 1 | 2004 | 32 | 0.210 |
Why?
|
| Bcl-2-Like Protein 11 | 2 | 2014 | 25 | 0.210 |
Why?
|
| Fatty Acids, Nonesterified | 8 | 2000 | 67 | 0.210 |
Why?
|
| Ginsenosides | 3 | 2012 | 124 | 0.210 |
Why?
|
| Time Factors | 23 | 2013 | 5576 | 0.210 |
Why?
|
| Mutation | 10 | 2001 | 4392 | 0.190 |
Why?
|
| Muscle Proteins | 1 | 2004 | 131 | 0.190 |
Why?
|
| Pulsatile Flow | 7 | 1996 | 50 | 0.190 |
Why?
|
| Genetic Therapy | 2 | 2003 | 373 | 0.190 |
Why?
|
| Point Mutation | 4 | 1997 | 237 | 0.190 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 196 | 0.180 |
Why?
|
| Nuclear Proteins | 4 | 2001 | 750 | 0.180 |
Why?
|
| Middle Aged | 47 | 2013 | 29442 | 0.180 |
Why?
|
| Proteins | 4 | 2001 | 804 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 11 | 2013 | 3598 | 0.180 |
Why?
|
| Cell Count | 2 | 2014 | 195 | 0.180 |
Why?
|
| Glucose Transporter Type 4 | 3 | 2006 | 18 | 0.170 |
Why?
|
| Cell Line, Tumor | 4 | 2016 | 2888 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 2 | 2014 | 256 | 0.170 |
Why?
|
| Glyburide | 3 | 1996 | 33 | 0.160 |
Why?
|
| Glycolysis | 2 | 1999 | 198 | 0.160 |
Why?
|
| Potassium Chloride | 5 | 2004 | 75 | 0.160 |
Why?
|
| Pedigree | 11 | 2003 | 980 | 0.160 |
Why?
|
| Diabetes, Gestational | 3 | 1995 | 51 | 0.160 |
Why?
|
| Body Weight | 10 | 2004 | 455 | 0.160 |
Why?
|
| Membrane Transport Proteins | 1 | 2001 | 169 | 0.160 |
Why?
|
| Panax | 3 | 2011 | 171 | 0.150 |
Why?
|
| Cell Line | 8 | 2014 | 2482 | 0.150 |
Why?
|
| Portal Vein | 11 | 2006 | 121 | 0.150 |
Why?
|
| Androgens | 3 | 1997 | 164 | 0.150 |
Why?
|
| Internship and Residency | 1 | 2009 | 1123 | 0.150 |
Why?
|
| Peptides | 7 | 2004 | 669 | 0.150 |
Why?
|
| Energy Metabolism | 4 | 2009 | 315 | 0.150 |
Why?
|
| Energy Intake | 4 | 2009 | 99 | 0.140 |
Why?
|
| Osmolar Concentration | 7 | 2001 | 166 | 0.140 |
Why?
|
| Cell Division | 2 | 2001 | 689 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 212 | 0.140 |
Why?
|
| Activity Cycles | 6 | 1998 | 19 | 0.140 |
Why?
|
| Membrane Potentials | 5 | 2006 | 406 | 0.140 |
Why?
|
| Blotting, Western | 3 | 2010 | 780 | 0.140 |
Why?
|
| Deoxyglucose | 3 | 2006 | 40 | 0.140 |
Why?
|
| Arachidonic Acid | 1 | 1998 | 63 | 0.140 |
Why?
|
| Insulin Infusion Systems | 3 | 1997 | 59 | 0.140 |
Why?
|
| Periodicity | 6 | 1999 | 115 | 0.140 |
Why?
|
| Postprandial Period | 5 | 2013 | 44 | 0.130 |
Why?
|
| Analysis of Variance | 8 | 2006 | 889 | 0.130 |
Why?
|
| Leptin | 5 | 2009 | 101 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 5 | 2009 | 81 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 4 | 2013 | 435 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 12 | 2 | 1996 | 64 | 0.130 |
Why?
|
| Homeostasis | 6 | 2006 | 474 | 0.130 |
Why?
|
| Adenosine Triphosphate | 5 | 2001 | 319 | 0.130 |
Why?
|
| Sleep | 4 | 1997 | 469 | 0.130 |
Why?
|
| Fibrinolysis | 1 | 1997 | 35 | 0.130 |
Why?
|
| Exercise | 2 | 2008 | 380 | 0.130 |
Why?
|
| Biological Clocks | 1 | 1998 | 74 | 0.130 |
Why?
|
| Pancreas Transplantation | 3 | 1993 | 120 | 0.130 |
Why?
|
| Perfusion | 6 | 2003 | 271 | 0.130 |
Why?
|
| Glycerolphosphate Dehydrogenase | 1 | 1996 | 7 | 0.130 |
Why?
|
| Thapsigargin | 3 | 2004 | 56 | 0.130 |
Why?
|
| Vitamin A | 3 | 1992 | 29 | 0.130 |
Why?
|
| Pyruvate Carboxylase | 1 | 1996 | 6 | 0.120 |
Why?
|
| Protein Precursors | 4 | 2001 | 133 | 0.120 |
Why?
|
| Adrenocortical Hyperfunction | 1 | 1996 | 6 | 0.120 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2016 | 18 | 0.120 |
Why?
|
| Injections, Intravenous | 8 | 2001 | 212 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1996 | 81 | 0.120 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2016 | 55 | 0.120 |
Why?
|
| Dog Diseases | 1 | 1996 | 36 | 0.120 |
Why?
|
| Arginine | 9 | 2009 | 143 | 0.120 |
Why?
|
| Steroids | 1 | 1997 | 168 | 0.120 |
Why?
|
| Lipoproteins, HDL | 2 | 1994 | 92 | 0.120 |
Why?
|
| Receptors, Drug | 2 | 2009 | 51 | 0.120 |
Why?
|
| Potassium Channels | 4 | 2001 | 349 | 0.110 |
Why?
|
| Organ Specificity | 5 | 2009 | 287 | 0.110 |
Why?
|
| Genotype | 3 | 2009 | 1888 | 0.110 |
Why?
|
| Ovary | 1 | 1997 | 260 | 0.110 |
Why?
|
| Growth Hormone | 7 | 1995 | 97 | 0.110 |
Why?
|
| Rats, Wistar | 6 | 2012 | 304 | 0.110 |
Why?
|
| Peptide Fragments | 5 | 2001 | 480 | 0.110 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2009 | 144 | 0.110 |
Why?
|
| Patch-Clamp Techniques | 3 | 2004 | 381 | 0.110 |
Why?
|
| Hypertriglyceridemia | 2 | 1994 | 71 | 0.110 |
Why?
|
| Ryanodine | 2 | 2004 | 4 | 0.100 |
Why?
|
| Dantrolene | 2 | 2004 | 5 | 0.100 |
Why?
|
| Food | 6 | 1996 | 93 | 0.100 |
Why?
|
| Research Personnel | 1 | 2015 | 87 | 0.100 |
Why?
|
| Lentivirus | 1 | 2014 | 44 | 0.100 |
Why?
|
| Missouri | 2 | 2013 | 26 | 0.100 |
Why?
|
| Gastric Emptying | 1 | 2013 | 26 | 0.100 |
Why?
|
| RNA, Small Interfering | 2 | 2014 | 564 | 0.100 |
Why?
|
| Insulinoma | 3 | 2004 | 39 | 0.100 |
Why?
|
| Phosphoproteins | 2 | 2009 | 264 | 0.100 |
Why?
|
| Administration, Oral | 6 | 1998 | 674 | 0.100 |
Why?
|
| Ovarian Diseases | 1 | 1993 | 28 | 0.100 |
Why?
|
| Haplotypes | 2 | 2014 | 656 | 0.100 |
Why?
|
| Blood Chemical Analysis | 1 | 1993 | 40 | 0.100 |
Why?
|
| Portraits as Topic | 1 | 2012 | 6 | 0.090 |
Why?
|
| Diet | 4 | 2009 | 469 | 0.090 |
Why?
|
| RNA Interference | 1 | 2014 | 388 | 0.090 |
Why?
|
| History, 19th Century | 1 | 2012 | 57 | 0.090 |
Why?
|
| Hyperthyroidism | 1 | 1993 | 77 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 413 | 0.090 |
Why?
|
| Recombinant Proteins | 5 | 1996 | 993 | 0.090 |
Why?
|
| Tolbutamide | 5 | 2001 | 16 | 0.090 |
Why?
|
| Jejunum | 1 | 2012 | 77 | 0.090 |
Why?
|
| Treatment Outcome | 6 | 2013 | 9713 | 0.090 |
Why?
|
| Duodenum | 1 | 2012 | 112 | 0.090 |
Why?
|
| Sulfonylurea Receptors | 2 | 2009 | 50 | 0.080 |
Why?
|
| Body Mass Index | 8 | 2009 | 850 | 0.080 |
Why?
|
| Phytotherapy | 2 | 2002 | 139 | 0.080 |
Why?
|
| Transgenes | 2 | 2008 | 173 | 0.080 |
Why?
|
| Microarray Analysis | 1 | 2010 | 96 | 0.080 |
Why?
|
| Organ Size | 4 | 2009 | 370 | 0.080 |
Why?
|
| Gastric Bypass | 1 | 2012 | 119 | 0.080 |
Why?
|
| Cyclophilins | 1 | 2010 | 8 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 373 | 0.080 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 5 | 2007 | 35 | 0.080 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2010 | 11 | 0.080 |
Why?
|
| Cholinergic Agonists | 1 | 2010 | 11 | 0.080 |
Why?
|
| Carbachol | 1 | 2010 | 34 | 0.080 |
Why?
|
| Hexoses | 1 | 1990 | 4 | 0.080 |
Why?
|
| Plant Extracts | 2 | 2002 | 252 | 0.080 |
Why?
|
| Overweight | 1 | 2011 | 123 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2006 | 370 | 0.080 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2009 | 32 | 0.080 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2009 | 11 | 0.080 |
Why?
|
| Beclin-1 | 1 | 2009 | 15 | 0.080 |
Why?
|
| Drug Synergism | 1 | 2010 | 317 | 0.070 |
Why?
|
| Radioimmunoassay | 12 | 1997 | 139 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2014 | 2555 | 0.070 |
Why?
|
| Culture Media | 1 | 2009 | 138 | 0.070 |
Why?
|
| Starvation | 1 | 2009 | 22 | 0.070 |
Why?
|
| Body Composition | 1 | 2009 | 88 | 0.070 |
Why?
|
| Personnel, Hospital | 1 | 2009 | 31 | 0.070 |
Why?
|
| DNA Fragmentation | 2 | 2000 | 65 | 0.070 |
Why?
|
| Washington | 1 | 2009 | 51 | 0.070 |
Why?
|
| Government Regulation | 1 | 2009 | 49 | 0.070 |
Why?
|
| Heparin | 4 | 1999 | 182 | 0.070 |
Why?
|
| Kidney | 3 | 1983 | 1123 | 0.070 |
Why?
|
| Glucagon-Secreting Cells | 1 | 2009 | 28 | 0.070 |
Why?
|
| Obesity, Morbid | 1 | 2012 | 252 | 0.070 |
Why?
|
| Program Development | 1 | 2009 | 141 | 0.070 |
Why?
|
| Intracellular Membranes | 2 | 2001 | 113 | 0.070 |
Why?
|
| Hospitals, Teaching | 1 | 2009 | 115 | 0.070 |
Why?
|
| Costs and Cost Analysis | 1 | 2009 | 155 | 0.070 |
Why?
|
| Adipose Tissue | 3 | 2006 | 280 | 0.070 |
Why?
|
| Carboxypeptidase H | 1 | 2008 | 12 | 0.070 |
Why?
|
| Universities | 1 | 2009 | 166 | 0.070 |
Why?
|
| Amino Acids | 1 | 2009 | 246 | 0.070 |
Why?
|
| Palmitates | 1 | 2008 | 17 | 0.070 |
Why?
|
| Cognition Disorders | 1 | 1990 | 240 | 0.070 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2009 | 186 | 0.070 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 334 | 0.070 |
Why?
|
| Prevalence | 1 | 2012 | 1383 | 0.070 |
Why?
|
| Workload | 1 | 2009 | 130 | 0.070 |
Why?
|
| United States | 3 | 2012 | 8193 | 0.070 |
Why?
|
| Immunohistochemistry | 4 | 2002 | 1815 | 0.070 |
Why?
|
| Sex Characteristics | 3 | 2004 | 351 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 6 | 1 | 2007 | 5 | 0.070 |
Why?
|
| Program Evaluation | 1 | 2009 | 346 | 0.070 |
Why?
|
| Schools, Medical | 1 | 2009 | 135 | 0.070 |
Why?
|
| Transcriptome | 1 | 2014 | 821 | 0.070 |
Why?
|
| Ion Channels | 2 | 2001 | 259 | 0.070 |
Why?
|
| Mice, Mutant Strains | 2 | 2008 | 217 | 0.070 |
Why?
|
| Mice, Obese | 3 | 2002 | 50 | 0.070 |
Why?
|
| Transplantation, Homologous | 2 | 2006 | 1026 | 0.070 |
Why?
|
| Career Choice | 1 | 2009 | 161 | 0.060 |
Why?
|
| Pancreatic Polypeptide | 4 | 1998 | 10 | 0.060 |
Why?
|
| Gonadotropins | 2 | 1997 | 32 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2005 | 1133 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2009 | 256 | 0.060 |
Why?
|
| Hepatocyte Nuclear Factor 1 | 4 | 2001 | 30 | 0.060 |
Why?
|
| Cognition | 1 | 1992 | 673 | 0.060 |
Why?
|
| Proteome | 1 | 2008 | 163 | 0.060 |
Why?
|
| Secretory Rate | 4 | 1993 | 13 | 0.060 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2006 | 3 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 257 | 0.060 |
Why?
|
| Protein Isoforms | 2 | 2004 | 303 | 0.060 |
Why?
|
| Microscopy, Confocal | 2 | 2004 | 285 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 310 | 0.060 |
Why?
|
| Histocompatibility Testing | 1 | 2006 | 145 | 0.060 |
Why?
|
| Amino Acid Sequence | 7 | 2000 | 2005 | 0.060 |
Why?
|
| Electron Transport | 1 | 2006 | 74 | 0.060 |
Why?
|
| Quantitative Trait Loci | 1 | 2010 | 663 | 0.060 |
Why?
|
| Brain | 3 | 1991 | 2448 | 0.060 |
Why?
|
| Chromosome Mapping | 3 | 2000 | 1061 | 0.060 |
Why?
|
| Enzyme Inhibitors | 2 | 1999 | 642 | 0.060 |
Why?
|
| Computational Biology | 1 | 2009 | 613 | 0.060 |
Why?
|
| Half-Life | 4 | 1987 | 89 | 0.060 |
Why?
|
| Cytosol | 1 | 2006 | 193 | 0.060 |
Why?
|
| Adolescent | 9 | 2001 | 10097 | 0.060 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2005 | 14 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2004 | 679 | 0.060 |
Why?
|
| NAD | 1 | 2006 | 102 | 0.060 |
Why?
|
| Molecular Sequence Data | 8 | 2000 | 2896 | 0.060 |
Why?
|
| Muscle Contraction | 1 | 2006 | 269 | 0.060 |
Why?
|
| Pancreatectomy | 3 | 1986 | 201 | 0.060 |
Why?
|
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 2 | 1996 | 13 | 0.050 |
Why?
|
| HLA Antigens | 1 | 2006 | 238 | 0.050 |
Why?
|
| Factor V | 1 | 2004 | 9 | 0.050 |
Why?
|
| Cell Separation | 3 | 2003 | 200 | 0.050 |
Why?
|
| Genes | 2 | 1995 | 256 | 0.050 |
Why?
|
| Protein Transport | 1 | 2006 | 448 | 0.050 |
Why?
|
| Epinephrine | 5 | 1992 | 92 | 0.050 |
Why?
|
| Proteomics | 1 | 2006 | 279 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 1566 | 0.050 |
Why?
|
| Palmitic Acids | 1 | 2004 | 8 | 0.050 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2004 | 6 | 0.050 |
Why?
|
| Oxazoles | 1 | 2004 | 14 | 0.050 |
Why?
|
| Macrocyclic Compounds | 1 | 2004 | 8 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 9 | 1997 | 308 | 0.050 |
Why?
|
| Reaction Time | 4 | 2002 | 325 | 0.050 |
Why?
|
| Matched-Pair Analysis | 1 | 2003 | 41 | 0.050 |
Why?
|
| Glucagon-Like Peptides | 1 | 2004 | 24 | 0.050 |
Why?
|
| Proprotein Convertase 1 | 1 | 2003 | 11 | 0.050 |
Why?
|
| Mathematics | 3 | 2005 | 178 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 1012 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2004 | 161 | 0.050 |
Why?
|
| Caspases | 1 | 2004 | 151 | 0.050 |
Why?
|
| Endocrine System | 1 | 2003 | 16 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2003 | 2572 | 0.050 |
Why?
|
| Age of Onset | 2 | 2001 | 368 | 0.050 |
Why?
|
| Human Growth Hormone | 3 | 2002 | 51 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2009 | 2585 | 0.050 |
Why?
|
| Endosomes | 1 | 2004 | 91 | 0.050 |
Why?
|
| Betacellulin | 1 | 2003 | 3 | 0.050 |
Why?
|
| Intestinal Absorption | 1 | 2003 | 125 | 0.050 |
Why?
|
| Dipeptides | 1 | 2003 | 41 | 0.050 |
Why?
|
| Spectrum Analysis | 2 | 1993 | 120 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2009 | 2037 | 0.050 |
Why?
|
| Lipolysis | 2 | 1994 | 24 | 0.050 |
Why?
|
| Superoxides | 1 | 2003 | 76 | 0.050 |
Why?
|
| Forecasting | 2 | 1996 | 295 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 1 | 2004 | 286 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2009 | 1790 | 0.050 |
Why?
|
| Immunoassay | 3 | 2008 | 102 | 0.050 |
Why?
|
| Pregnancy | 5 | 2001 | 3244 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2004 | 269 | 0.050 |
Why?
|
| Aged | 15 | 2012 | 21760 | 0.050 |
Why?
|
| Risk Factors | 3 | 2009 | 6232 | 0.050 |
Why?
|
| Tissue Distribution | 4 | 1997 | 290 | 0.050 |
Why?
|
| Base Sequence | 6 | 1996 | 2222 | 0.050 |
Why?
|
| Acromegaly | 1 | 2002 | 5 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 5 | 1997 | 895 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2004 | 484 | 0.050 |
Why?
|
| Anti-Obesity Agents | 1 | 2002 | 18 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2003 | 340 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2003 | 318 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2003 | 419 | 0.040 |
Why?
|
| Diterpenes | 2 | 1992 | 24 | 0.040 |
Why?
|
| Genetic Markers | 3 | 2000 | 471 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 2004 | 264 | 0.040 |
Why?
|
| Intestine, Small | 1 | 2003 | 318 | 0.040 |
Why?
|
| Uncoupling Protein 2 | 1 | 2001 | 11 | 0.040 |
Why?
|
| Uncoupling Agents | 1 | 2001 | 15 | 0.040 |
Why?
|
| Electric Conductivity | 1 | 2001 | 144 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2002 | 340 | 0.040 |
Why?
|
| Indians, North American | 1 | 2001 | 49 | 0.040 |
Why?
|
| Pregnancy in Diabetics | 1 | 2001 | 43 | 0.040 |
Why?
|
| Disease Susceptibility | 2 | 2004 | 226 | 0.040 |
Why?
|
| Carrier Proteins | 2 | 2009 | 667 | 0.040 |
Why?
|
| Cross-Over Studies | 2 | 2013 | 410 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2000 | 87 | 0.040 |
Why?
|
| Receptors, Cell Surface | 2 | 1997 | 291 | 0.040 |
Why?
|
| Biomarkers | 3 | 2013 | 2022 | 0.040 |
Why?
|
| Oligopeptides | 1 | 2001 | 207 | 0.040 |
Why?
|
| Somatostatin-28 | 4 | 1983 | 4 | 0.040 |
Why?
|
| Adipocytes | 1 | 2001 | 179 | 0.040 |
Why?
|
| bcl-X Protein | 1 | 2000 | 57 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2008 | 977 | 0.040 |
Why?
|
| Nitrendipine | 1 | 1999 | 5 | 0.040 |
Why?
|
| Diazoxide | 1 | 1999 | 19 | 0.040 |
Why?
|
| Diabetic Neuropathies | 4 | 1988 | 44 | 0.040 |
Why?
|
| Pancreatic Hormones | 2 | 1991 | 17 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 3 | 1997 | 769 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 1999 | 118 | 0.040 |
Why?
|
| Polymorphism, Genetic | 2 | 2000 | 831 | 0.040 |
Why?
|
| Glyceraldehyde | 1 | 1998 | 4 | 0.040 |
Why?
|
| Dietary Fats | 3 | 2008 | 135 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 1999 | 227 | 0.040 |
Why?
|
| Calcium-Transporting ATPases | 1 | 1998 | 27 | 0.030 |
Why?
|
| Intracellular Fluid | 1 | 1998 | 32 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 1998 | 24 | 0.030 |
Why?
|
| Wakefulness | 2 | 1995 | 130 | 0.030 |
Why?
|
| Chromatography, Gel | 4 | 1992 | 96 | 0.030 |
Why?
|
| Transfection | 2 | 2004 | 883 | 0.030 |
Why?
|
| Cholesterol | 3 | 2002 | 373 | 0.030 |
Why?
|
| Hexokinase | 1 | 1997 | 23 | 0.030 |
Why?
|
| Double-Blind Method | 3 | 1998 | 1783 | 0.030 |
Why?
|
| Leuprolide | 1 | 1997 | 34 | 0.030 |
Why?
|
| Pregnancy, Animal | 1 | 1997 | 58 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 1997 | 162 | 0.030 |
Why?
|
| Consumer Behavior | 1 | 1997 | 35 | 0.030 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 1997 | 46 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2001 | 594 | 0.030 |
Why?
|
| Keratins | 1 | 1997 | 62 | 0.030 |
Why?
|
| Succinate Dehydrogenase | 1 | 1996 | 17 | 0.030 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 1996 | 17 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 1996 | 111 | 0.030 |
Why?
|
| Phosphorylation | 3 | 2006 | 1145 | 0.030 |
Why?
|
| Regression Analysis | 4 | 2000 | 580 | 0.030 |
Why?
|
| Diabetic Angiopathies | 1 | 1996 | 40 | 0.030 |
Why?
|
| RNA, Transfer, Leu | 1 | 1996 | 14 | 0.030 |
Why?
|
| Infusions, Parenteral | 2 | 1986 | 47 | 0.030 |
Why?
|
| Purinergic P2 Receptor Agonists | 1 | 1996 | 2 | 0.030 |
Why?
|
| Child | 4 | 2001 | 7699 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2001 | 727 | 0.030 |
Why?
|
| Deafness | 1 | 1996 | 50 | 0.030 |
Why?
|
| Keratinocytes | 1 | 1997 | 156 | 0.030 |
Why?
|
| Acarbose | 1 | 1995 | 2 | 0.030 |
Why?
|
| Trisaccharides | 1 | 1995 | 13 | 0.030 |
Why?
|
| Uterus | 1 | 1997 | 232 | 0.030 |
Why?
|
| Weaning | 1 | 1995 | 26 | 0.030 |
Why?
|
| Liver Circulation | 4 | 1983 | 28 | 0.030 |
Why?
|
| Skin Transplantation | 1 | 1997 | 192 | 0.030 |
Why?
|
| Phenotype | 3 | 2003 | 2638 | 0.030 |
Why?
|
| Causality | 1 | 1995 | 83 | 0.030 |
Why?
|
| Age Factors | 2 | 1997 | 1967 | 0.030 |
Why?
|
| Electrophysiology | 1 | 1996 | 389 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2009 | 720 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 1997 | 393 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 1996 | 226 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1999 | 640 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2006 | 2787 | 0.030 |
Why?
|
| Uncertainty | 1 | 2015 | 81 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2001 | 3213 | 0.030 |
Why?
|
| Pulse | 1 | 1994 | 14 | 0.030 |
Why?
|
| Diet, Diabetic | 1 | 1994 | 3 | 0.030 |
Why?
|
| Adenoma, Islet Cell | 2 | 1986 | 28 | 0.030 |
Why?
|
| Cholesterol, HDL | 2 | 1994 | 173 | 0.030 |
Why?
|
| Cell Dedifferentiation | 1 | 2014 | 10 | 0.030 |
Why?
|
| Femoral Artery | 2 | 1986 | 96 | 0.030 |
Why?
|
| Expert Testimony | 1 | 2014 | 34 | 0.030 |
Why?
|
| Preventive Medicine | 1 | 2014 | 19 | 0.030 |
Why?
|
| Receptors, Neurotensin | 1 | 2013 | 3 | 0.030 |
Why?
|
| Inulin | 1 | 1993 | 17 | 0.030 |
Why?
|
| Plaque, Amyloid | 1 | 2014 | 69 | 0.030 |
Why?
|
| Testosterone | 1 | 1995 | 265 | 0.030 |
Why?
|
| DNA | 3 | 1997 | 1274 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 2 | 2007 | 32 | 0.020 |
Why?
|
| Antisense Elements (Genetics) | 1 | 1993 | 9 | 0.020 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2014 | 98 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2014 | 123 | 0.020 |
Why?
|
| Blood Pressure | 2 | 1996 | 910 | 0.020 |
Why?
|
| Family | 1 | 1995 | 327 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 126 | 0.020 |
Why?
|
| Glycerol | 1 | 1993 | 35 | 0.020 |
Why?
|
| Insulin Antibodies | 1 | 1992 | 2 | 0.020 |
Why?
|
| Adenylate Kinase | 1 | 2012 | 14 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 839 | 0.020 |
Why?
|
| Lipid Metabolism | 2 | 1990 | 221 | 0.020 |
Why?
|
| Transcriptional Activation | 2 | 2004 | 293 | 0.020 |
Why?
|
| Body Surface Area | 1 | 1992 | 38 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 1993 | 230 | 0.020 |
Why?
|
| Fruit | 2 | 2002 | 81 | 0.020 |
Why?
|
| Lipase | 1 | 1991 | 22 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2012 | 346 | 0.020 |
Why?
|
| Plant Preparations | 1 | 2011 | 20 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2014 | 489 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1992 | 287 | 0.020 |
Why?
|
| Self Care | 1 | 1992 | 189 | 0.020 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1990 | 32 | 0.020 |
Why?
|
| Somatomedins | 1 | 1990 | 28 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2010 | 34 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2010 | 84 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 1990 | 31 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 137 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2010 | 84 | 0.020 |
Why?
|
| Actins | 1 | 1993 | 480 | 0.020 |
Why?
|
| Myocardium | 1 | 1993 | 578 | 0.020 |
Why?
|
| Perilipin-1 | 1 | 2009 | 7 | 0.020 |
Why?
|
| Fluorine Radioisotopes | 1 | 1990 | 25 | 0.020 |
Why?
|
| Child, Preschool | 4 | 2001 | 4006 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 1990 | 104 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 1990 | 110 | 0.020 |
Why?
|
| Thyroxine | 1 | 1993 | 411 | 0.020 |
Why?
|
| Remission Induction | 1 | 2012 | 754 | 0.020 |
Why?
|
| Evoked Potentials, Visual | 1 | 1990 | 90 | 0.020 |
Why?
|
| Algorithms | 2 | 2000 | 2009 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2010 | 241 | 0.020 |
Why?
|
| Hybridization, Genetic | 1 | 2010 | 107 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 588 | 0.020 |
Why?
|
| Streptozocin | 1 | 2009 | 57 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 1990 | 146 | 0.020 |
Why?
|
| Physical Exertion | 1 | 1988 | 39 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2010 | 524 | 0.020 |
Why?
|
| Basal Metabolism | 1 | 1988 | 19 | 0.020 |
Why?
|
| Cyclosporins | 1 | 1988 | 56 | 0.020 |
Why?
|
| Placebos | 2 | 1999 | 209 | 0.020 |
Why?
|
| Heterozygote | 2 | 2001 | 390 | 0.020 |
Why?
|
| Animal Feed | 1 | 2008 | 22 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 2008 | 50 | 0.020 |
Why?
|
| Molecular Weight | 5 | 1990 | 280 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2004 | 1784 | 0.020 |
Why?
|
| Calibration | 1 | 2008 | 110 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2008 | 102 | 0.020 |
Why?
|
| Sweetening Agents | 1 | 2007 | 17 | 0.020 |
Why?
|
| Heterochromatin | 1 | 2007 | 27 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 1988 | 239 | 0.020 |
Why?
|
| Reference Standards | 1 | 2008 | 146 | 0.020 |
Why?
|
| Young Adult | 2 | 2012 | 7511 | 0.020 |
Why?
|
| Inflammation | 1 | 2014 | 1120 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2008 | 191 | 0.020 |
Why?
|
| Golgi Apparatus | 1 | 2008 | 111 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 220 | 0.020 |
Why?
|
| X Chromosome | 1 | 2007 | 154 | 0.020 |
Why?
|
| Clinical Chemistry Tests | 1 | 2007 | 11 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 1988 | 263 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2006 | 4026 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2007 | 144 | 0.020 |
Why?
|
| Alleles | 1 | 2010 | 1159 | 0.020 |
Why?
|
| In Situ Hybridization | 2 | 1997 | 306 | 0.020 |
Why?
|
| Transplantation, Autologous | 4 | 1991 | 395 | 0.020 |
Why?
|
| Computer Simulation | 1 | 1991 | 1153 | 0.020 |
Why?
|
| International Cooperation | 1 | 2007 | 132 | 0.020 |
Why?
|
| Hepatic Veins | 2 | 1983 | 27 | 0.020 |
Why?
|
| Opportunistic Infections | 1 | 2006 | 57 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2006 | 54 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2006 | 24 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2006 | 85 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2009 | 350 | 0.010 |
Why?
|
| Glycogen | 1 | 2006 | 58 | 0.010 |
Why?
|
| Syndrome | 1 | 1987 | 439 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2005 | 7387 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1990 | 450 | 0.010 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2006 | 72 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 1990 | 834 | 0.010 |
Why?
|
| Autonomic Nervous System | 2 | 1983 | 70 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 1992 | 939 | 0.010 |
Why?
|
| Isoantibodies | 1 | 2006 | 135 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1996 | 403 | 0.010 |
Why?
|
| Cloning, Molecular | 2 | 1996 | 581 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 53 | 0.010 |
Why?
|
| DNA Primers | 2 | 1996 | 530 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2004 | 80 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2004 | 195 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2004 | 139 | 0.010 |
Why?
|
| Transplantation Conditioning | 1 | 2006 | 388 | 0.010 |
Why?
|
| Graft Survival | 1 | 1988 | 994 | 0.010 |
Why?
|
| Plasmids | 1 | 2004 | 275 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2006 | 803 | 0.010 |
Why?
|
| Gastrins | 1 | 2003 | 15 | 0.010 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2003 | 13 | 0.010 |
Why?
|
| Calcitonin | 1 | 2003 | 41 | 0.010 |
Why?
|
| Endothelium | 1 | 2004 | 63 | 0.010 |
Why?
|
| Renin | 1 | 2003 | 69 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2004 | 402 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1990 | 831 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 142 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2004 | 276 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 2 | 1997 | 412 | 0.010 |
Why?
|
| Sugar Alcohol Dehydrogenases | 1 | 1983 | 2 | 0.010 |
Why?
|
| Imidazolidines | 1 | 1983 | 3 | 0.010 |
Why?
|
| Aldehyde Reductase | 1 | 1983 | 10 | 0.010 |
Why?
|
| Intercalating Agents | 1 | 2003 | 11 | 0.010 |
Why?
|
| Ethidium | 1 | 2003 | 13 | 0.010 |
Why?
|
| Hepatectomy | 1 | 1984 | 203 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2004 | 310 | 0.010 |
Why?
|
| Heart Rate | 3 | 1996 | 536 | 0.010 |
Why?
|
| Neural Conduction | 1 | 1983 | 73 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2004 | 518 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 889 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 700 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1982 | 167 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2002 | 21 | 0.010 |
Why?
|
| Imidazoles | 1 | 1983 | 142 | 0.010 |
Why?
|
| Saponins | 1 | 2002 | 41 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2002 | 102 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2002 | 131 | 0.010 |
Why?
|
| Arizona | 1 | 2001 | 10 | 0.010 |
Why?
|
| Body Constitution | 1 | 2001 | 26 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2004 | 720 | 0.010 |
Why?
|
| Cell Size | 1 | 2001 | 71 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1984 | 314 | 0.010 |
Why?
|
| Nuclear Family | 1 | 2001 | 92 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 1013 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2002 | 118 | 0.010 |
Why?
|
| Pituitary Neoplasms | 1 | 2002 | 74 | 0.010 |
Why?
|
| Stem Cells | 1 | 2004 | 395 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 1985 | 583 | 0.010 |
Why?
|
| Antibodies | 1 | 1983 | 349 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 126 | 0.010 |
Why?
|
| Estradiol | 1 | 2002 | 268 | 0.010 |
Why?
|
| Finland | 1 | 2000 | 31 | 0.010 |
Why?
|
| Fetus | 1 | 2001 | 237 | 0.010 |
Why?
|
| Mexican Americans | 1 | 2000 | 72 | 0.010 |
Why?
|
| Mothers | 1 | 2001 | 146 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2001 | 113 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2003 | 525 | 0.010 |
Why?
|
| Metyrapone | 1 | 1999 | 3 | 0.010 |
Why?
|
| Adenoma | 1 | 2002 | 260 | 0.010 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 1999 | 15 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1999 | 93 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1999 | 201 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2000 | 715 | 0.010 |
Why?
|
| Homozygote | 1 | 1998 | 212 | 0.010 |
Why?
|
| Rats, Mutant Strains | 1 | 1997 | 23 | 0.010 |
Why?
|
| Receptors, Leptin | 1 | 1997 | 34 | 0.010 |
Why?
|
| Oxygen | 1 | 2003 | 801 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 1997 | 67 | 0.010 |
Why?
|
| Proline | 1 | 1997 | 51 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1996 | 119 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 244 | 0.010 |
Why?
|
| Neuropeptide Y | 1 | 1996 | 29 | 0.010 |
Why?
|
| Gastrectomy | 1 | 1997 | 75 | 0.010 |
Why?
|
| Oscillometry | 1 | 1996 | 25 | 0.010 |
Why?
|
| Genomic Imprinting | 1 | 1996 | 32 | 0.010 |
Why?
|
| Adenosine Monophosphate | 1 | 1996 | 31 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 1996 | 61 | 0.010 |
Why?
|
| Thionucleotides | 1 | 1996 | 54 | 0.010 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 1996 | 40 | 0.010 |
Why?
|
| Societies, Scientific | 1 | 1996 | 40 | 0.010 |
Why?
|
| Prognosis | 1 | 2004 | 4116 | 0.010 |
Why?
|
| Adenine | 1 | 1996 | 101 | 0.010 |
Why?
|
| Pituitary-Adrenal System | 1 | 1995 | 69 | 0.010 |
Why?
|
| Cattle | 1 | 1996 | 397 | 0.010 |
Why?
|
| Hypogonadism | 1 | 1995 | 43 | 0.010 |
Why?
|
| Genome, Human | 1 | 2000 | 832 | 0.010 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1995 | 83 | 0.010 |
Why?
|
| Guanine | 1 | 1996 | 194 | 0.010 |
Why?
|
| Feedback | 1 | 1995 | 132 | 0.010 |
Why?
|
| Lipoproteins, HDL2 | 1 | 1994 | 5 | 0.010 |
Why?
|
| Lipoproteins, HDL3 | 1 | 1994 | 8 | 0.010 |
Why?
|
| Glucose Transporter Type 2 | 1 | 1994 | 12 | 0.010 |
Why?
|
| Particle Size | 1 | 1994 | 129 | 0.010 |
Why?
|
| Molecular Probes | 1 | 1994 | 38 | 0.010 |
Why?
|
| Veins | 1 | 1994 | 87 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1994 | 435 | 0.010 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1993 | 72 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1996 | 1255 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1997 | 911 | 0.010 |
Why?
|
| Skin | 1 | 1997 | 592 | 0.010 |
Why?
|
| Fatty Acids | 1 | 1993 | 147 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2004 | 2680 | 0.010 |
Why?
|
| Adenosine | 1 | 1996 | 291 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1997 | 1568 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1992 | 107 | 0.010 |
Why?
|
| Creatinine | 1 | 1992 | 313 | 0.010 |
Why?
|
| Denervation | 1 | 1991 | 26 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1991 | 63 | 0.010 |
Why?
|
| Hepatic Artery | 2 | 1981 | 84 | 0.010 |
Why?
|
| Sex Factors | 1 | 1994 | 1138 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2002 | 3618 | 0.000 |
Why?
|
| Regional Blood Flow | 2 | 1981 | 194 | 0.000 |
Why?
|
| Anaerobiosis | 1 | 1988 | 21 | 0.000 |
Why?
|
| Cardiac Output | 1 | 1988 | 142 | 0.000 |
Why?
|
| Models, Theoretical | 1 | 1990 | 508 | 0.000 |
Why?
|
| Respiration | 1 | 1988 | 275 | 0.000 |
Why?
|
| Cross Reactions | 1 | 1986 | 115 | 0.000 |
Why?
|
| Papio | 1 | 1986 | 91 | 0.000 |
Why?
|
| Stroke Volume | 1 | 1988 | 464 | 0.000 |
Why?
|
| Swine | 1 | 1987 | 593 | 0.000 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 1985 | 25 | 0.000 |
Why?
|
| Liver Regeneration | 1 | 1984 | 34 | 0.000 |
Why?
|
| Infant | 1 | 1991 | 3332 | 0.000 |
Why?
|
| Tissue Donors | 1 | 1988 | 581 | 0.000 |
Why?
|
| Injections, Subcutaneous | 1 | 1984 | 141 | 0.000 |
Why?
|
| Liver Cirrhosis | 1 | 1986 | 288 | 0.000 |
Why?
|
| Renal Circulation | 1 | 1983 | 30 | 0.000 |
Why?
|
| Chromatography | 1 | 1983 | 25 | 0.000 |
Why?
|
| Peroneal Nerve | 1 | 1983 | 9 | 0.000 |
Why?
|
| Skin Temperature | 1 | 1983 | 16 | 0.000 |
Why?
|
| Drug Evaluation | 1 | 1983 | 109 | 0.000 |
Why?
|
| Median Nerve | 1 | 1983 | 13 | 0.000 |
Why?
|
| Antibody Specificity | 1 | 1983 | 126 | 0.000 |
Why?
|
| Random Allocation | 1 | 1983 | 312 | 0.000 |
Why?
|
| Epitopes | 1 | 1983 | 258 | 0.000 |
Why?
|
| Portal System | 1 | 1981 | 12 | 0.000 |
Why?
|
| Kidney Failure, Chronic | 1 | 1986 | 445 | 0.000 |
Why?
|
| Secretin | 1 | 1981 | 6 | 0.000 |
Why?
|
| Motor Neurons | 1 | 1983 | 192 | 0.000 |
Why?
|
| Species Specificity | 1 | 1982 | 690 | 0.000 |
Why?
|